IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer
This study has been terminated.
(The study was terminated because Cell Genesys stopped all activities for GVAX.)
Sponsor:
VU University Medical Center
Collaborators:
Cell Genesys
Medarex
Information provided by (Responsible Party):
A.J.M. van den Eertwegh, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01510288
First received: January 4, 2012
Last updated: January 10, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | November 2011 |
| Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):